Navigation Links
Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade.
Date:7/31/2008

BASINGSTOKE, England and PHILADELPHIA, July 31 /PRNewswire-FirstCall/ -- Shire Limited (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company announces results for the three months to June 30, 2008.
Q2 2008 Financial Highlights

- Product sales up 40% to $706m

- Product sales excluding ADDERALL XR(R) up 64% to $409m

- New product sales(1) $243m, 34% of product sales (2007: 18%)

- Total revenues up 35% to $776m

- US GAAP earnings per ADS: loss $0.44 (2007: loss $9.93)

- Non GAAP earnings per ADS up 70% to $0.95 (2007: $0.56)

- Revenue guidance upgraded - 2008 revenue growth now expected to

be at least 20% (previous guidance: mid to high teens)

(1) New product sales comprise DAYTRANA, ELAPRASE, FOSRENOL, LIALDA /

MEZAVANT and VYVANSE

Angus Russell, Chief Executive Officer, commented:

"Shire continues to deliver strong growth and broaden its business in specialty biopharmaceuticals. Our product sales for the quarter were up 40% on Q2 2007 with sales of new products now comprising 34% of total product sales. At $409m, product sales excluding ADDERALL XR were up 64% reflecting the success of our strategy to build a pipeline and portfolio for Shire's future growth.

"We are pleased with the performance of ELAPRASE, FOSRENOL, LIALDA, REPLAGAL and VYVANSE and are looking forward to the continued growth of VYVANSE in the US supplemented by the recent launch of the adult indication, the additional dosage strengths and the back-to-school season.

"We have decided to commence a phased discontinuation of DYNEPO. Resources supporting this product will be re-directed to faster growing, profitable core global products.

"The proposed acquisition of Jerini AG in Germany, which we expect to complete in Q3, is an excellent match for our business and we expect to benefit from both its near term revenues and long term growth. The recent EU approval of Je
'/>"/>

SOURCE Shire Ltd
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Shire Appoints Sylvie Gregoire President of Human Genetic Therapies Business
2. Shires ELAPRASE(R) (idursulfase) Approved in Japan for the Treatment of Hunter Syndrome
3. Shire Divests Non-Core Product Portfolio to Almirall
4. Correction: Shire plc: Third Quarter 2007 results date notification November 1, 2007
5. David Mott Appointed Non Executive Director at Shire
6. Shire plc: Board Changes
7. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
8. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
9. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
10. Texas Boy Receives Wheelchair From New Hampshire Couples Recently Deceased Granddaughter
11. Shire Engages Palio

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...stCall/ -- BioSpecifics Technologies Corp. (Nasdaq...first-in-class collagenase-based products, today a...er ended September 30, 2009. ,, "We were extre...A,s Arthritis Advisory Committee unanimously recom...(TM) for the treatment of Dupuytren,s disease, and...
(Date:11/5/2009)...FirstCall/ -- Wound Management Technologies, Inc.,...a Letter of Intent to purchase all healthcare-rela...TC Bulletin Board: VHGI). The deal provides for VH...00 shares of WNDM and a royalty agreement for reve... being acquired from VHGI. WNDM closed at $2.00 ...
(Date:11/5/2009)...rstCall/ -- WaferGen Biosystems, Inc. (OTC Bulleti...e-art genetic analysis systems, today announced th...,s Scientific Advisory Board. His career has been...lecular diagnostics for cancer detection and other...onal biology systems for several biotechnology com...
(Date:11/5/2009)...ewswire-Asia-FirstCall/ -- BMP Sunstone,Corporatio...") today announced,that the Company plans to relea... November 9, 2009, after the market closes. ,...00 pm ET on November 9, 2009,to discuss third quar...y,dialing 1-888-713-4211 or 1-617-213-4864 for int...
Breaking Biology Technology:BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4BMP Sunstone to Report Third Quarter 2009 Financial Results 2
...arly in the hands of people. While the movement to...um in an effort to reduce testing efforts and maxi...ty-wide controls rely upon people. , ,Investing in...entity-wide controls, is a company,s safest bet to...ies. Competent people working within a healthy con...
...as been awarded a $275,000 climate change grant, b...adison-based energy business announced it will rec...urce of the grant comes from down under - the New... Change in Australia. , ,The department,s technol...of technologies and processes that minimize greenh...
...dd the Olympics to their list of great accomplishm...rastructure with more than just a third-party Wi-F...yond national comparisons on Wi-Fi and into the re...ant investments in fiber optics. , , Look around, ...t third party Wi-Fi is the ultimate answer is fool...
Other Biology Technology:Technology helps but the best way to reduce Sarbox cost is with people 2Technology helps but the best way to reduce Sarbox cost is with people 3Technology helps but the best way to reduce Sarbox cost is with people 4No network infrastructure, no Olympics, no nothing 2No network infrastructure, no Olympics, no nothing 3No network infrastructure, no Olympics, no nothing 4No network infrastructure, no Olympics, no nothing 5No network infrastructure, no Olympics, no nothing 6
(Date:11/6/2009)...2009) The Monell Center and the Chinese Academy o...national Meeting on Taste and Smell Research. Orga... meeting will be the first international meeting o...shner, Chief Executive Officer, American Associati...blisher of Science magazine, will open the meeting...
(Date:11/4/2009)...ral science) , United States Using Less Water ... than it did 35 years ago, despite a 30 percent po...y attributable to alternative cooling methods at p... According to the latest USGS water use report, ne...oes to cooling thermoelectric power plants. Irriga...
(Date:11/4/2009)...at Norman has received more than $10 million in re...f the federal stimulus program, bringing thetotal ...ers to $23 million. Thirty-three projects achieve...ology to weather. , "The university has thoughtf...areasof scholarly excellence to federal agency pri...
Breaking Biology News(10 mins):Monell Center joins with CAS to host Beijing meeting on taste and smell research 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3Seniors Launch Campaign to Have a Fair Say on Health Care Reform 57210 1Seniors Launch Campaign to Have a Fair Say on Health Care Reform 57210 2Seniors in Medicare Advantage Receive Higher Quality Care New Reports Show 57206 1Seniors in Medicare Advantage Receive Higher Quality Care New Reports Show 57206 2Seniors in Medicare Advantage Receive Higher Quality Care New Reports Show 57206 3Poll Shows Liberals Opposed to Extending Taxpayer Funded Healthcare to Illegal Immigrants 57202 1Poll Shows Liberals Opposed to Extending Taxpayer Funded Healthcare to Illegal Immigrants 57202 2
... The regions in robins, brains responsible for sin... levels of DDT, says new University of Alberta res...contaminant damages the brain of a wild animal. ...ate 1960s--that,s what is really disturbing," said...ow in the U of A,s Department of Psychology. "It h...
... Plasminogen Activator Inhibitor Type 2 (PAI-2), a... skin, has been discovered in the tissue covering ...in various pathologies of the ocular surface such ...ers at the University of Pennsylvania and Temple U...Giordano, M.D., of the University of Pennsylvania,...
... The secret weapon of bacteria -- the way they get...less of a secret, according to research published ... , Under study is the bacterial pathogen Pseudomo... bacterial speck. The pathogen reared its speckled...ntist Sheng Yang He describes using P. syringae in...
Other Biology News:Bird brains shrink from exposure to contaminants 2Promising cell protein may play role in infection and dry eye 2
...lectrophoresis (2D-PAGE) with biological mass spec...latform for proteomic analysis. 2D-PAGE gels offer...limited only in the dynamic range and ability to r...e based analysis of separated proteins has been a ...
...lectrophoresis (2D-PAGE) with biological mass spec...latform for proteomic analysis. 2D-PAGE gels offer...limited only in the dynamic range and ability to r...e based analysis of separated proteins has been a ...
...ypeptide sequence corresponding to Tyr89 Gly265 o... a recombinant soluble proform of MT1-MMP purified...ecific activity of MT1-MMP catalytic domain is = 1...s 1 mol peptide (7-methoxycoumarin-4-yl)acetyl-Pro...
Anti-Interferon-beta (IFNb) Monoclonal Antibody, Unconjugated from CHEMICON
Biology Products: